Pyrazinamide and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Pyrazinamide (pyrazinamide), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Isoniazid, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Septic shock when taking Pyrazinamide. It is created by eHealthMe based on reports of 10,019 people who have side effects when taking Pyrazinamide from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,746 drugs and 3,391 conditions by eHealthMe. Check the latest studies of Septic shock.

On Jul, 05, 2026

10,019 people reported to have side effects when taking Pyrazinamide.
Among them, 83 people (0.83%) have Septic shock.

Among these 83 people:

How long have people been on Pyrazinamide when they have Septic shock? *

What is the gender of people who have Septic shock when taking Pyrazinamide? *

female: 57.33 %
male: 42.67 %

What is the age of people who have Septic shock when taking Pyrazinamide? *

What are other drugs people take besides Pyrazinamide? *

Isoniazid: 33 people, 39.76%
Rifampin: 23 people, 27.71%
Voriconazole: 10 people, 12.05%
Piperacillin And Tazobactam: 10 people, 12.05%
Vancomycin: 8 people, 9.64%
Methylene Blue: 7 people, 8.43%
Epinephrine: 7 people, 8.43%
Ciclosporin: 6 people, 7.23%
Linezolid: 5 people, 6.02%
Milrinone Lactate: 4 people, 4.82%

What are other side effects people have besides Septic shock? *

Sepsis (a severe blood infection that can lead to organ failure and death): 26 people, 31.33%
Pneumonia: 22 people, 26.51%
Disseminated Tuberculosis: 17 people, 20.48%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 14 people, 16.87%
Anaemia (lack of blood): 14 people, 16.87%
Fever: 13 people, 15.66%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 13 people, 15.66%
Pleural Effusion (water on the lungs): 13 people, 15.66%
Staphylococcal Infection (an infection with staphylococcus bacteria): 12 people, 14.46%
Multi-Organ Failure (multisystem organ failure): 12 people, 14.46%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 10 people, 12.05%
Hiv Infection: 8 people, 9.64%
Hypotension (abnormally low blood pressure): 7 people, 8.43%
Tuberculosis Gastrointestinal (a bacterial infection of digestive tract by mycobacterium tuberculosis): 6 people, 7.23%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 6 people, 7.23%
Immunodeficiency Disorders: 4 people, 4.82%
Disseminated Tuberculosis: 3 people, 3.61%
Fungal Infection: 3 people, 3.61%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 3.61%
Infection: 3 people, 3.61%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pyrazinamide:

Pyrazinamide (10,062 reports)

Septic shock treatments and more:

Septic shock (51,128 reports)

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Septic shock (1,746 drugs)

Browse all the conditions that are associated with Septic shock:

Septic shock (3,391 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide (the active ingredients of Pyrazinamide) and Pyrazinamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.